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Abstract
Background: Patients who experience severe brain injuries are at risk of secondary brain damage, because of
delayed vasospasm and edema. Traditionally, many of these patients are kept on prolonged bed rest in order to
maintain adequate cerebral blood flow, especially in the case of subarachnoid hemorrhage. On the other hand,
prolonged bed rest carries important morbidity. There may be a clinical benefit in early mobilization and our
hypothesis is that early gradual mobilization is safe in these patients. The aim of this study was to observe and
quantify the changes in sympathetic activity, mainly related to stress, and blood pressure in gradual postural
changes by the verticalization robot (Erigo®) and after training by a lower body ergometer (MOTOmed-letto®), after
prolonged bed rest of minimum 7 days.
Methods: Thirty patients with severe neurological injuries were randomized into 3 groups with different protocols
of mobilization: Standard, MOTOmed-letto® or Erigo® protocol. We measured plasma catecholamines,
metanephrines and blood pressure before, during and after mobilization.
Results: Blood pressure does not show any significant difference between the 3 groups. The analysis of the
catecholamines suggests a significant increase in catecholamine production during Standard mobilization with
physiotherapists and with MOTOmed-letto® and no changes with Erigo®.
Conclusions: This preliminary prospective randomized study shows that the mobilization of patients with severe
brain injuries by means of Erigo® does not increase the production of catecholamines. It means that Erigo® is a
well-tolerated method of mobilization and can be considered a safe system of early mobilization of these patients.
Further studies are required to validate our conclusions.
Trial registration: The study was registered in the ISRCTN registry with the trial registration number
ISRCTN56402432. Date of registration: 08.03.2016. Retrospectively registered.
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Background
Severe acute neurological conditions, such as subarach-
noid hemorrhage, head trauma and large brain infarcts,
may be associated with severe cardiovascular manifesta-
tions, such as myocardial ischemia, arrhythmias, hyper-
tension and neurogenic pulmonary edema [1].
Patients who experience severe brain injuries are also
at risk of secondary brain damage, because of delayed
vasospasm and edema. Common practice in our hos-
pital, especially in the Intensive Care Unit, is to keep
these patients on prolonged bed rest in order to main-
tain adequate blood flow to the brain. However, the data
supporting this practice are limited [2].
Autoregulation of cerebral blood flow is partly medi-
ated by the activation of the autonomic system, mainly
in the form of sympathetic effects. The autonomic sys-
tem is an internal regulatory system of the central ner-
vous network involved in visceromotor, neuroendocrine
and pain mechanisms, essential for survival. The brain
controls preganglionic sympathetic and parasympathetic
outputs and receives visceroceptive, humoral and extero-
ceptive information. Both systems are activated by in-
ternal and external factors and modulate neuronal
activity, cerebral blood flow and metabolism [1].
The autonomic system is critical for reflex adjustments
of cardiovascular responses. It has an influence on car-
diac rate and vasomotor tone, with the aim of adjusting
circulatory balance [3].
The sympathetic components of the autonomic system
are mainly activated in times of stress; the production of
catecholamines in the adrenal glands and the sympa-
thetic nerve endings results in a significant increase in
systolic and diastolic blood pressure and heart rate [4].
It is well known that prolonged bed rest carries import-
ant morbidity, especially in the elderly, including cardio-
vascular, respiratory, musculoskeletal, hematological and
cognitive events. The supine position decreases for in-
stance the ventilatory volume and impairs the clearing of
secretions, resulting in atelectasis and pneumonia.
Immobilization results in electrolyte imbalance [2, 5].
Prolonged inactivity leads also to deconditioning. One
key feature in this process could be reduced blood vol-
ume, occurring after a few days of bed rest [6]. These
complications appear during the first days of bed rest
and add severe problems to the already devastating
neurological injury. Another aspect to consider – in the
long term- is the cardiac remodeling and change in sym-
pathetic nerve function, which can also contribute to
orthostatic intolerance after long-lasting inactivity.
Many animal and human studies suggest that intermit-
tent exposure to gravity during a long period of bed rest
is sufficient to prevent deconditioning [6] and improve
outcome after awakening from coma [7]. Verticalization
is integrated in a neurosensorial approach in acute
neurorehabilitation and improves the results of weaning
training [8]. This is the reason why rehabilitation protocols
should ideally begin as soon as the patient is stabilized, in
order to reduce prolonged bed rest complications, stimu-
late the afferent sensory system and reduce spasticity in
some patients.
The aim of our study was to observe and quantify the
changes in sympathetic activity with gradual postural
changes (Erigo®) and with leg movements alone
(MOTOmed®) after prolonged bed rest. Our hypothesis
is that the gradual mobilization of neurologically im-
paired patients with these systems avoids orthostatic
hypotension with a compensatory peak of catechol-
amines (adrenaline, noradrenaline and dopamine) and
thus is a safe method of early mobilization in patients
with neurological deficits and may prevent further com-
plications of prolonged bed rest.
The study was realized by the Acute Neurorehabilita-
tion Unit team, in cooperation with the Intensive Care
Unit, the departments of Neurology and Neurosurgery
and the Biomedical laboratory of the University Hospital
in Lausanne.
Methods
Patient population
Thirty patients were evaluated between July 2012 and
September 2014 in the Intensive or Intermediate Care
Unit. In our University Hospital, the decision to admit a
patient in the Intensive rather than Intermediate Care
Unit depends on different criteria, including the need of
mechanical ventilation and of important medical support
for cardiovascular and respiratory functions. In both
Units, patients are monitored 24 h/24. Eighteen patients
were hospitalized under Neurosurgery responsibility, 1
under Neurology responsibility, 4 in the Neurorehabilita-
tion Unit and 7 in the Intensive Care Unit (ICU).
All patients included in this study were adults
(≥18 years old), had a severe neurological injury, trau-
matic or non-traumatic, and had a period of bed rest of
minimum 7 days before the first mobilization out of
bed. Exclusion and inclusion criteria for the study are
shown in Table 1.
Fourteen patients had subarachnoid hemorrhage, 4
patients had severe brain trauma, 4 patients had
intra-parenchymal hemorrhage, 2 patients had an is-
chemic vascular accident, 3 patients had brain anoxia
and 3 patients had other injuries (epilepsy in brain
dysplasia; empyema; coma of undetermined origin).
Demographic data of the patient population are
shown in Table 2.
Mobilization protocol
This study is a single center, parallel-group study, with
simple equal randomization (1:1:1). Patients were
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randomized into three groups of 10 patients: Group 1
“Standard Protocol”, Group 2 “MOTOmed® Protocol”
and Group 3 “Erigo® Protocol”. The randomization was
made by means of a computer program, which randomly
coupled each patient with a number from 1 to 3, corre-
sponding to the mobilization protocol the patient would
have. These three groups are equally heterogeneous in
terms of age, sex and type of pathologies of the patients
included in them (Table 3).
MOTOmed Letto® (Reck & Co. GmbH, Germany) is
an automatic system for leg mobilization in a supine
position, miming a bicycle, which allows passive, active
or assisted mobilization for patients on prolonged bed
rest.
Erigo® (Hocoma AG, Switzerland) is a tilting table with
an integrated leg movement system, which allows pro-
gressive verticalization of the patient, adjustable to
patient needs and possibilities.
For all patients, we defined T0 as their time of admis-
sion to our hospital, T1 as their admission to the Inter-
mediate Care Unit (excepted for the patients who were
so far in the ICU), T2 as the moment directly before the
first mobilization out of bed, T3 during the first
mobilization out of bed and T4 one hour after lying in
Table 1 Inclusion and exclusion criteria for the study
Inclusion criteria for Groups 1, 2, 3
• Age≥18
• Severe neurological injury
• Bed rest≥7 days
• Continuous monitoring in the Intensive or Intermediate Care Unit
• Signed informed consent
Exclusion criteria for Group 2
• Amputation of a leg, with impossibility to pedal
• Trauma or previous surgery of the feet, pelvis or lumbar column
• Abdominal open wound
• Extreme obesity (BMI> 35)
• Ulcers
• Height <150cm
• Psychiatric disease or severe agitation
Exclusion criteria for Group 3
• Fixed contractions of the legs
• Weight >135 kg
• Leg length <70 cm or > 102 cm
• Bone instability
• Open ulcers or vascular disease of the legs
• Cardiac contro-indications
• Inadequate cooperation of the patient
Table 2 Demographic data
Mean age in years (range) 54.2 (18–88)
Gender Number of patients
• Male 17
• Female 13
Diagnosis Number of patients
• Subarachnoid hemorrhage 14
• Severe brain trauma 4
• Intra-parenchymal hemorrhage 4
• Ischemic vascular accident 2
• Brain anoxia 3
• Others 3
Table 3 Patients’ features and their randomization
Patient Age Sex Diagnositic Mobilization
protocol
1 46 M SAH 1
2 52 M SAH 3
3 63 M SAH 2
4 37 M SBT 3
5 37 M SBT 3
6 44 M SAH 1
7 88 F SAH 3
8 31 F SAH 1
9 72 F IPH 2
10 22 M Epilepsy 1
11 54 F SAH 3
12 86 M IPH 1
13 62 F IPH 2
14 18 M IVA 2
15 62 M Empyema 3
16 55 M SAH 2
17 23 F SBT 1
18 79 F SBT 1
19 25 F IPH 2
20 53 F SAH 2
21 34 M SAH 3
22 63 M SAH 1
23 51 M BA 1
24 81 M BA 2
25 85 M Coma 3
26 42 M IVA 2
27 75 F SAH 3
28 64 F BA 3
29 60 F SAH 1
30 64 F SAH 2
M male, F female, SAH subarachnoid hemorrhage, SBP severe brain trauma, IPH
intra-parenchymal hemorrhage, IVA ischemic vascular accident, BA brain anoxia
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bed again. Catecholamines and metanephrines were
measured at T2, T3 and T4 and cardio-respiratory
parameters (blood pressure, heart rate and respiratory
rate) at T1, T2, T3 and T4. For patients with SAH, a
transcranial Doppler was realized at T1, T2 and T4.
All the patients were mobilized every day in bed from
their admission. Patients in group 1 and 3 were mobi-
lized in bed by physiotherapists, according to usual clin-
ical physiotherapy standard recommendations in our
hospital. Patients in group 2 were mobilized in bed by
either physiotherapists and with a MOTOmed® session
of almost 30 min 5 days/week. Then, after a minimum
of 7 days, all the patients were mobilized out of bed.
Patients in group 1 were mobilized out of bed only by
physiotherapists. The physiotherapists measured the
cardio-respiratory vital signs (T2), put the patient in a
sitting position on the bed for 5 min, then in an upright
position (T3) and finally reinstalled him lying in bed for
one hour (T4).
Patients in group 2 were mobilized out of bed by phys-
iotherapists for the first time after the MOTOmed®
session on T3.
Patients in group 3 were mobilized out of bed with
a 3 step Erigo® session: during the first step (5 min)
the patient was in the supine position, with the head
at 0°, and the Erigo® started leg movements (T2); dur-
ing the second step (30 min) the patient was progres-
sively put in a vertical position (at 30°–50°–70° for
10 min each) while the Erigo® continued to move the
patient’s legs (T2.1, T2.2 and T3); during the third
step (10 min) the patient was returned to a supine
position (Table 4).
All SAH patients had multiple transcranial Dopplers,
in order to monitor cerebral blood flow velocity. Data
were recorded at the moment of admission to the Inten-
sive Care Unit, just before and after mobilization. The
transcranial Doppler was realized in patients in a supine
position, with a Philips IU 22 echograph and a S5-2
transcranial probe.
Catecholamine assays
Venous blood samples for catecholamines (Epinephrine
(E), Norepinephrine (NE)) determination were collected
in heparinized tubes (10 mL), which were immediately
placed on ice. Plasma was decanted by centrifugation at
3000 rpm at 4 °C and frozen until analysis. Catechol-
amine concentrations were determined using tandem
mass spectrometry [9].
Plasma free metanephrines (Metanephrine (M), Nor-
metanephrine (NM)) and Methoxytyramine (MT)) were
determined by tandem mass spectrometry in the same
samples [10] at T2, T3 and T4 time. Reference intervals
in our laboratory are: 0.02–1.23 nmol/l for Epinephrine,
0.64–6.55 nmol/l for Norepinephrine, 0.03–0.85 nmol/l
for Metanephrine, 0.04–1.39 nmol/l for Normetanephr-
ine and <0.06 nmol/l for Methoxytyramine. MT was
assessed in the aim of controlling the blood sample and
the laboratory analysis, as this hormone is not influenced
by the mobilization procedure.
At the same time, we measured the three components
of the arterial blood pressure (BP): the mean, the dia-
stolic and the systolic arterial pressures, because they
reflect differently the orthosympathetic activity.
Patients did not have coffee, tea, chocolate, citrus
fruits or bananas for at least 6 h before the test, and
were not taking medication interfering with catechol-
amine metabolism.
Statistical analysis
Statistical procedures were performed using Matlab®
R2011a (The MathWorks, Inc., Natick, Massachusetts,
USA, http://www.mathworks.com) in order to test for
differences for absolute and relative differences in all BP
components and in hormone rates, observed before
(T2), during (T3) and after mobilization (T4).
We assessed the absolute and the relative differences
of the response of interest (either BP or hormonal rates
for E, NE, M, NM and MT) for each mobilization pro-
cedure. Absolute difference was calculated by
Table 4 Measurements’ protocol and time points for Group 1, Group 2 and Group 3
T0 T1 (Gr 1,2,3) T2 (Gr 1,2,3) T2.1 (Only Gr 3) T2.2 (Only Gr 3) T3 (Gr 1,2,3) T4 (Gr 1,2,3)
Admission
to CHUV
Admission to
Intermediate
Care Unit
First mobilizationout
of bed. In supine position,
15min before mobilization
After 5 min in 30°
vertical position
After 5 min in 50°
vertical position
After 5 min in stand
position for Gr 1, 2
and in 70° vertical
position for Gr 3
After 60 min in
supine position
SBP x x x x x x x
DBP x x x x x x x
HR x x x x x x x
RR x x x x x x x
Catech. x x x
Doppler If SAH If SAH If SAH
Gr 1 (group 1): Standard Protocol; Gr 2 (group 2): MOTOmed® Protocol; Gr 3 (group 3): Erigo® Protocol
SBP systolic blood pressure, DBP diastolic blood pressure, HR heart rate, RR respiratory rate, Catech catecholamine
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subtracting the values observed at two different times,
and we assessed the relative difference by calculating the
percentage between values also measured at two differ-
ent times. Hence, for each mobilization procedure and
for each response of interest, 3 groups of difference were
formed (difference between T2 and T3 values, between
T2 and T4 values, and between T3 and T4 values) pro-
viding together 54 data sets.
Then, we applied a normality test (Lilliefort test) on
each group and the null hypothesis of normality was
rejected for many data sets, therefore, a non-parametric
test, the Wilcoxon signed-rank test, was preferred; the
Bonferroni-Holm (BH) method was applied for the cor-
rection of multiple comparisons. Finally, statistical infer-
ence was processed by testing the null hypothesis that
data in each group came from a symmetric distribution
with zero median, against the alternative that the distri-
bution did not have zero median. We also tested the null
hypothesis that data in two different groups of difference
were independent samples from identical distributions
with equal medians, against the alternative that they did
not have equal medians.
Results
Thirty patients were enrolled and 3 had to be excluded
afterwards because they received Noradrenalin treatment
just before the evaluation at time point T2 (2 patients of
group 1 and 1 patient of group 2).
MT concentrations were not affected by the
mobilization, providing evidence that the procedure for
taking blood samples and laboratory analyses remained
free of technical bias. Otherwise, neither in single group
testing, nor in group comparison, did T4 data provide
significant differences when compared with T2 or T3
data. This may be explained by the inter-patients vari-
ability of neurotransmitter concentrations (delayed plas-
matic peak, continuous production after mobilization).
Therefore, we excluded all T4 data from our analysis
reducing our data set to 18, which allowed us to lower
the significance threshold by reducing BH correction for
multiple comparisons.
In single group testing, various results were obtained
with explicit homogeneity between absolute and relative
differences. Firstly, no significant absolute or relative differ-
ence was observed for any of the BP components; such re-
sults may be explained by the high variability of the values
measured in a small sample size. Secondly, some neuro-
transmitter rates changed after mobilization. Indeed, sig-
nificant absolute and relative increases in E rate were
measured both after MOTOmed® (identical p = 0.023 for
slope measure and for percentage after BH correction) and
standard mobilization (identical p = 0.046 for slope meas-
ure and for percentage after BH correction); increase of E
plasma levels was higher after MOTOmed® mobilization
than after standard mobilization. M plasma levels rose also
significantly after MOTOmed® (identical p = 0.023 for ab-
solute and relative differences after BH correction),
whereas NM rates increased after standard mobilization
(identical p = 0.046 for absolute and relative differences
after BH correction). In contrast, Erigo® mobilization did
not cause a significant rise of the blood level of any hor-
mone (p > 0.05 for E, NE, M, NM and MT using the BH
method for multiple comparison correction) in terms of
absolute and relative differences. Detailed statistical results
for each response of interest are presented in Fig. 1.
Group comparison did not show any significant differ-
ence irrespective of the methods. In terms of location of
sample distributions for E, M and NM hormones, all
value distributions are closely located together to the
right of the median 0 with the Erigo® distribution situ-
ated between the median 0 and both other distributions.
Discussion
Commonly in our hospital, severe brain injured patients
are kept on prolonged bed rest because of the fear of
impairing cerebral blood flow during mobilization, espe-
cially but not only in the case of SAH. On the other
hand, it is well known that prolonged bed rest increases
the risk of cardiovascular, respiratory and musculoskel-
etal problems, especially in the elderly, from as early as
the first days of bed rest.
Based on this consideration, we carried out a prelimin-
ary study on severely brain-injured patients, trying to
prove the safety of early mobilization in controlled con-
ditions and its potential clinical benefits. We believe that
rehabilitation protocols should ideally begin as soon as
possible, in order to reduce complications, but also to
stimulate the afferent sensory system in some patients.
Our hypothesis was that gradual mobilization with the
verticalization robot Erigo® or lower body ergometer
MOTOmed® would be less stressful for these patients
than simple mobilization with physiotherapists (Stand-
ard protocol) after prolonged bed rest, thus causing a
lower increase in plasmatic catecholamines and less
hypotensive events during mobilization.
The study was conducted on patients who had a
period of bed rest of minimum 7 days before the first
mobilization out of bed. The delay of 7 days was
chosen for different reasons. First of all because it is
the standard care for patients with severe brain injur-
ies in our Intensive Care Unit. Then, because there
are some evidences in the literature that, during the
first week, the sympathetic system is overactivated in
patients with cerebral tissue damages of different ori-
gin and a stable situation is restored after 7 days [11].
On the other hand, the literature shows that, after a
week of bed rest, many systems start to fail (respira-
tory, musculoskeletal…). The idea of the study was
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therefore to collect data during this period of sympa-
thetic system new stability, before the failure of other
systems begins.
As reported by Yamanouchi [12] and Rössler [13],
when a normal subject assumes an upright position,
500–700 ml of his blood is pooled in the lower-body
vascular beds and in the splanchnic circulation. This re-
distribution of blood reduces central venous pressure
and systemic arterial pressure, activating afferent signals
of the sympathetic system. Consequently, we observe
vasoconstriction, increased heart rate and an enhanced
inotropic state, due to the increase in catecholamines,
mainly norepinephrine [4]. All these responses are
dependent on the age and physical fitness of the person,
but also on their sleep-wake cycle, emotional state,
attention and other factors [1].
Regarding blood pressure, some studies show that
mobilization with Erigo® or MOTOmed® does not cause
a significant drop in blood pressure in comparison with
pre- mobilization values [14]. This could be an indirect
demonstration that these systems reduce orthostatic in-
tolerance, a well described phenomenon in the literature,
due to prolonged inactivity [6].
Our statistical analysis of the blood pressure does not
show any significant difference between the 3 groups.
Based on our data, we cannot demonstrate any effect of
the type of mobilization on the blood pressure. We can
only observe a tendency towards a higher prevalence of
hypotensive events in the group of patients mobilized
only by physiotherapists: 6 patients of group 1 showed a
hypotensive event versus 2 patients in each of the other
2 groups. The explanation for this lack of statistical sig-
nificance might be due to the small sample size and the
relatively high variability of the BP values in the very
acute phase.
The analysis of the catecholamine results is more com-
plex. The interpretation of a “normal sympathetic re-
sponse” to stress is complicated by the fact that subtle
abnormalities in autonomic control are described in many
studies, as for example those occurring with smoking, [15]
in diabetic patients [16] and in patients with inflammatory
pathologies [17]. This could be a first problem in our
study, because of the heterogeneity of our groups. In
addition to this, plasma norepinephrine in venous blood
depends on several factors, including local sympathetic ac-
tivity and the rate of reuptake and extraction by forearm
tissues. Therefore, interpretations based on forearm
venous sampling of catecholamines may not necessarily
reflect directly systemic autonomic activity, as reported by
Vlcek et al. [4] and by Naredi et al. [18].
Fig. 1 Box and whisker plots of the differences of the mean arterial blood pressure and of the neurotransmitters blood levels (epinephrine,
norepinephrine, metanephrine, normetanephrine, methoxytyramine) between T2 (immediately before mobilization) and T3 (during mobilization)
for the three modalities (standard physiotherapy, MOTOmed®, Erigo®). Null hypothesis of the Wilcoxon non-parametric test is tested for a symmetric
distribution with zero median; significance level is 0.05 after Bonferroni-Holm correction for multiple comparisons. Legends: the red line inside the
box represents the median, the blue edges of the box the 25th and 75th percentiles, the black lines the 1st and 99th percentiles, and the red crosses the outliers
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In 2000, Naredi et al. [18] published a very important
study performed to understand the relationship between
catecholamines and the risk of vasospasm in patients
with SAH. They identified a dramatic elevation in
sympathetic activity in patients after SAH, persisting
for 7 days after the hemorrhage. The same data were
observed by Takizawa et al. [19], Lambert et al. [20]
and Iseda et al. [21]. Naredi also identified a relation-
ship between sympatho-excitation and local constric-
tion of small vessels that supply the brainstem. The
possible physiopathology of this bilateral relationship
is well described by Gao et al. [22]. They identified in
the abrupt increase in intracranial pressure (ICP) after
SAH the possible primum movens of vasospasm. The
marked increase in ICP decreases cerebral perfusion
pressure and results in the brainstem becoming ische-
mic, with lower partial oxygen pressure and the
release of neurotransmitters, which induce excitation
of the sympathetic center. Some other studies suggest
the possibility that elevated levels of catecholamines,
coupled with abnormal sensitivity of the cerebral vas-
culature, may be involved in the genesis of vasospasm
[23, 24]. Some studies also showed that the use of
norepinephrine as a hypertensive therapy post-SAH could
be a potential aggravator of cerebral vasospasm [25].
Our data suggest a significant increase in epinephrine
secretion during mobilization with physiotherapists
alone and with MOTOmed®. This difference was con-
firmed by the increase of metanephrine, the O-
methylated metabolite of epinephrine. No statistical
changes in catecholamine production were observed
during mobilization with Erigo®. There is no catechol-
amine that is overproduced during mobilization with
Erigo® and the catecholamine levels remain stable during
the rest period after mobilization.
As epinephrine is exclusively produced in the adrenal
glands and reflects a response to mental or metabolic
stress, its stability after Erigo® mobilization could suggest
that the progressive verticalization by the robot reduces
the stress emotion in these patients. The increased pro-
duction of catecholamines as an indirect sign of stress
was also discussed by Benarroch [1]. It means that, if we
compare these three methods of mobilization, the Erigo®
could be the best tolerated. There are many studies
which demonstrate that patients better tolerate Erigo®
than other tilt tables, in terms of greater degrees of head
up tilt [26] and better stabilization of blood pressure
[27] and heart rate [16]. Our hypothesis is that the key
factor is the very slow and progressive mobilization
allowed by Erigo®, which can be adapted to the patient
response.
The most important change in catecholamine pro-
duction during mobilization is observed in the group
of patients mobilized with MOTOmed®. We should
keep in mind this result, because of the potential risk
of increasing vasospasm connected to the high levels
of catecholamines [25] produced during MOTOmed®
exercise in patients with SAH. On the other hand, in
patients with other neurological pathologies, the
stimulation of the sympathetic system should have a
positive effect.
In our series, we also tried to quantify the increased
risk of vasospasm during mobilization by means of
trans-cranial Doppler. We only recorded one case of
vasospasm, not clinically significant (in a patient mobi-
lized by Erigo®).
Our study shows interesting results but has some
limits. The first and most important one is related to the
small number of included patients. This is the reason
why we consider it a preliminary study. The second limit
is the heterogeneity of neurological conditions we exam-
ined. Unfortunately, because of the small number of
subjects, a “subgroup analysis” based on the different
pathologies is impossible in our study, but could be an
interesting prospective for the future. The multiplicity
of factors that may influence plasma catecholamine
levels could also play a role in the interpretation of
our results. For example, the majority of the patients
admitted to the Intensive Care Unit were under medi-
cations which could affect blood pressure and heart
rate. Moreover all patients with SAH are treated in
our hospital by means of hypervolemia and hyperten-
sive therapy, in order to reduce the risk of vaso-
spasm. All these treatments can affect sympathetic
system and might have an influence on the interpret-
ation of our data. Nevertheless, it is important to
consider the absolute need of these therapies in the
standard care for such patients. For this reason, get-
ting rid of the effects caused by these treatments is
extremely difficult, if Intensive Care Unit patients are
included in the study. For the present study, we
decided to exclude from our statistical analysis only
those patients under medications which directly affect
catecholamine metabolism.
Conclusions
This preliminary prospective randomized study shows
that the mobilization of patients with severe brain injur-
ies by means of robot Erigo® does not increase the pro-
duction of catecholamines. It can be considered a safe
method for the early mobilization of these patients with-
out stress, in order to reduce the risk of complications
connected to prolonged bed rest.
Our study also shows that mobilization with the
lower body ergometer MOTOmed® brings an import-
ant stimulation of the sympathetic system, with an in-
crease in the production of catecholamines. For this
reason, MOTOmed® should be used with caution in
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patients with SAH, because of the potential risk of
vasospasm related to the elevation of catecholamines,
but can be indicated to prevent polyneuromyopathy
of critical care illness or improve the awareness of
disorders of consciousness.
Because of the small number of patients included in our
series, their heterogeneity and the relatively large number
of outliers, further studies are required to validate our
findings about the safety in the use of early robotic
mobilization in the Intensive and Intermediate Care Unit.
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